We are live on
!
Find out more
RJA
Raymond James & Associates Portfolio holdings
AUM
$164B
1-Year Est. Return
33.91%
This Fund
S&P 500
This Quarter
Est. Return
+7.15%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+221.81%
AUM
$164B
AUM Growth
+$11.8B
(+7.7%)
Cap. Flow
+$2.23B
Cap. Flow
% of AUM
1.36%
Top 10 Holdings %
Top 10 Hldgs %
25.88%
Holding
4,146
New
203
Increased
1,918
Reduced
1,677
Closed
157
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$520M |
| 2 |
UnitedHealth
UNH
|
+$332M |
| 3 |
Analog Devices
ADI
|
+$320M |
| 4 |
Fidelity National Information Services
FIS
|
+$265M |
| 5 |
iShares Core US Aggregate Bond ETF
AGG
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Min Vol Factor ETF
USMV
|
+$516M |
| 2 |
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
|
+$512M |
| 3 |
Cisco
CSCO
|
+$348M |
| 4 |
Apple
AAPL
|
+$162M |
| 5 |
Devon Energy
DVN
|
+$142M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.27% |
| 2 | Financials | 8.92% |
| 3 | Healthcare | 7.98% |
| 4 | Industrials | 6.57% |
| 5 | Consumer Discretionary | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PHT
3776
DELISTED
Pioneer High Income Fund
PHT
| $101K | ﹤0.01% |
12,633
-1,020
| -7% | -$7.91K |
|
3777
PUT
iShares Russell 2000 ETF
IWM
$80.4B
| $100K | ﹤0.01% |
600
-7,000
| -92% | -$1.5M |
|
3778
Cibus
CBUS
$148M
| $100K | ﹤0.01% |
30,698
+16,250
| +112% | +$118K |
|
3779
PUT
Dick's Sporting Goods
DKS
$18.9B
| $100K | ﹤0.01% |
+500
| New | +$107K |
|
3780
The Honest Company
HNST
$421M
| $98.4K | ﹤0.01% |
27,562
-5,000
| -15% | -$18.7K |
|
|
SOL
3781
DELISTED
Emeren Group
SOL
| $97.2K | ﹤0.01% |
+36,000
| New | +$67K |
|
3782
SIGA Technologies
SIGA
$240M
| $95.7K | ﹤0.01% |
14,172
-675
| -5% | -$5.89K |
|
3783
Coursera
COUR
$1.68B
| $95K | ﹤0.01% |
11,970
+712
| +6% | +$5.62K |
|
3784
Sasol
SSL
$7.03B
| $95K | ﹤0.01% |
+14,050
| New | +$104K |
|
3785
ADT
ADT
$5.38B
| $94.8K | ﹤0.01% |
13,113
-3,040
| -19% | -$22.3K |
|
3786
PUT
AT&T
T
$169B
| $94.5K | ﹤0.01% |
6,300
| – | – |
|
3787
Altimmune
ALT
$581M
| $94.4K | ﹤0.01% |
15,368
-6,623
| -30% | -$44.9K |
|
|
GLQ
3788
Clough Global Equity Fund
GLQ
$152M
| $93.6K | ﹤0.01% |
13,482
+1,757
| +15% | +$12K |
|
3789
Gerdau
GGB
$9.72B
| $91.2K | ﹤0.01% |
26,050
-2,708
| -9% | -$8.87K |
|
3790
PUT
Dycom Industries
DY
$12.1B
| $90K | ﹤0.01% |
500
| – | – |
|
|
ASG
3791
Liberty All-Star Growth Fund
ASG
$324M
| $89.2K | ﹤0.01% |
15,897
-584
| -4% | -$3.15K |
|
3792
Evolution Petroleum
EPM
$131M
| $88.4K | ﹤0.01% |
16,656
-164,089
| -91% | -$865K |
|
3793
EyePoint Inc
EYPT
$1B
| $85.8K | ﹤0.01% |
+10,739
| New | +$94.3K |
|
3794
Universal Safety Products Inc
UUU
$9.54M
| $85.3K | ﹤0.01% |
73,513
| – | – |
|
3795
MiMedx Group
MDXG
$649M
| $84.2K | ﹤0.01% |
14,242
-1,017
| -7% | -$6.74K |
|
|
ESPR
3796
DELISTED
Esperion Therapeutics
ESPR
| $83.6K | ﹤0.01% |
50,657
-6,220
| -11% | -$12.6K |
|
3797
CS Disco
LAW
$270M
| $83.1K | ﹤0.01% |
14,130
| – | – |
|
3798
Rockwell Medical
RMTI
$27.6M
| $81K | ﹤0.01% |
+2,040
| New | +$54.9K |
|
3799
PUT
Costco
COST
$429B
| $80K | ﹤0.01% |
100
| – | – |
|
3800
Acacia Research
ACTG
$447M
| $78.3K | ﹤0.01% |
16,800
-302
| -2% | -$1.49K |
|
Similar funds
RJFSA
PI
ECU
EAM
AA
SA
WPL
ECU
Raymond James & Associates's Q3 2024 Portfolio in Review
As of Q3 2024, Raymond James & Associates held 4,146 positions worth $164B, up 7.7% from $152B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Raymond James & Associates's Q3 2024 filing shows 203 new, 1,918 increased, 1,677 reduced and 157 closed positions. Its largest new stake was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M. The largest sale was iShares MSCI USA Min Vol Factor ETF, an estimated $516M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Raymond James & Associates's largest Q3 2024 buy was AllianzIM U.S. Equity Buffer20 Aug ETF: 724,171 shares worth $20.9M.
- Raymond James & Associates added most to iShares Core S&P Mid-Cap ETF in Q3 2024, an estimated $520M increase.
- Raymond James & Associates's biggest Q3 2024 reduction was iShares MSCI USA Min Vol Factor ETF, cutting an estimated $516M.
- Raymond James & Associates fully exited Ferguson in Q3 2024, selling an estimated $63.3M.
- Raymond James & Associates's ten largest holdings make up 26% of its $164B portfolio in Q3 2024.
- Raymond James & Associates opened 203 new positions and closed 157 in Q3 2024.
- Raymond James & Associates's portfolio value rose 7.7% quarter-over-quarter to $164B.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.